November 30, 2009
DES MOINES, IowaKemin Foods, L.C. and OmniActive Health Technologies, Inc. and OmniActive Health Technologies, Ltd. reached an amicable settlement of their patent dispute. Terms of the settlement were not disclosed.
The parties agreed that Kemin's US Patent No. 5,382,714 ("the '714 patent") titled "Process for Isolation, Purification and Recrystallization of Lutein from Saponified Marigold Oleoresin and Uses Thereof" and the reissues of that patent are valid and enforceable. In conjunction with the settlement, OmniActive will promote and sell its newly launched Lutemax 2020 products.
You May Also Like
Advancing gender equity in the nutraceutical industrySep 25, 2023
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Exercise recovery: Electrolytes, hydration and combating fatigue – SupplySide intensive webinarSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023